News

Founding SOM faculty to deliver Pearson Lecture '... Not for the Faint of Heart'

If you are curious about what it takes to be a pioneer, you won’t want to miss the 2023 Emmett F. Pearson Memorial Medical Lecture, “The Early History of SIU School of Medicine - Not for the Naïve or the Faint of Heart.” Glen Davidson, PhD, founding chair of SIU’s Department of Medical Humanities, will share his recollections beginning at 5 p.m., Tuesday, September 12, in the South Auditorium, 801 N. Rutledge, in Springfield. A reception will follow in the Pearson Museum. Davidson’s talk will draw upon the formative years at SIU School of Medicine. He was hired as an associate professor of
News

Founding SOM faculty to deliver Pearson Lecture '... Not for the Faint of Heart'

If you are curious about what it takes to be a pioneer, you won’t want to miss the 2023 Emmett F. Pearson Memorial Medical Lecture, “The Early History of SIU School of Medicine - Not for the Naïve or the Faint of Heart.” Glen Davidson, PhD, founding chair of SIU’s Department of Medical Humanities, will share his recollections beginning at 5 p.m., Tuesday, September 12, in the South Auditorium, 801 N. Rutledge, in Springfield. A reception will follow in the Pearson Museum. Davidson’s talk will draw upon the formative years at SIU School of Medicine. He was hired as an associate professor of
News

Founding SOM faculty to deliver Pearson Lecture '... Not for the Faint of Heart'

If you are curious about what it takes to be a pioneer, you won’t want to miss the 2023 Emmett F. Pearson Memorial Medical Lecture, “The Early History of SIU School of Medicine - Not for the Naïve or the Faint of Heart.” Glen Davidson, PhD, founding chair of SIU’s Department of Medical Humanities, will share his recollections beginning at 5 p.m., Tuesday, September 12, in the South Auditorium, 801 N. Rutledge, in Springfield. A reception will follow in the Pearson Museum. Davidson’s talk will draw upon the formative years at SIU School of Medicine. He was hired as an associate professor of
Trial
Neurology

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Active recruiting

The primary objective is to assess the effect of XEN1101 versus placebo on reducing PGTCS frequency in subjects with PGTCS.

Trial
Neurology

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Active recruiting

The primary objective of this study is to assess the effect of XEN1101 versus placebo on reducing focal seizure frequency.

Subscribe to